Farallon Capital Management »

Jatt Ii Acquisition Corp shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Jatt Ii Acquisition Corp shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Jatt Ii Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Jatt Ii Acquisition Corp held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jatt Ii Acquisition Corp by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.4M 300k 11.36

More positions owned by Farallon Capital Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Revolution Medicines (RVMD)
Electronic Arts (EA)
Bridgebio Pharma (BBIO)
Protagonist Therapeutics (PTGX)
Exelixis (EXEL)
Liquidia Corporation Com New (LQDA)
Amazon (AMZN)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Natera (NTRA)
UnitedHealth (UNH)
Thermo Fisher Scientific (TMO)
Roivant Sciences SHS (ROIV)
Aon Shs Cl A (AON)
Boston Scientific Corporation (BSX)

View all positions for Farallon Capital Management

Top funds holding Jatt Ii Acquisition Corp

Dr. Jeffrey R. Jay, M.D.
Jupiter Topco
Balyasny Asset Management
RA Capital Management
ADAR1 Capital Management
Franklin Resources
Atika Capital Management
Citadel Advisors
Farallon Capital Management
Braidwell
Nantahala Capital Management
Affinity Asset Advisors
TCG Crossover Management
Spruce Street Capital
Millennium Management

View all funds holding Jatt Ii Acquisition Corp